Si-bone, INC Form 4 insider transactions

NASDAQ
Anshul Maheshwari, CFO of SI-BONE, Inc., reports the acquisition and disposition of company stock on September 3, 2024, according to a Form 4 filing.
NASDAQ
Anthony J. Recupero, President of Commercial Operations at SI-BONE, Inc., sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
NASDAQ
Anshul Maheshwari, CFO of SI-BONE, Inc., sold shares to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
SI-BONE CEO Laura Francis sold shares of common stock on August 16, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
Director Jeffrey W. Dunn sold 1,580 shares of SI-BONE, Inc. to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
Director Daniel W. Wolf acquired 17,182 shares of SI-BONE, Inc. common stock on August 5, 2024, through the settlement of restricted stock units.
NASDAQ
Director Jeffrey W. Dunn sold 343 shares of SI-BONE, Inc. to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
Anthony Recupero, President of Commercial Operations at SI-BONE, Inc., sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
Anshul Maheshwari, CFO of SI-BONE, Inc., sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
Thomas A. West, a director at SI-BONE, Inc., filed an amended Form 4 to correct the number of shares issuable on the settlement of restricted stock units, clarifying that 18,315 shares are involved.
NASDAQ
Director Thomas A. West acquired 8,791 shares of SI-BONE, Inc. common stock on June 26, 2024, through the settlement of restricted stock units.
NASDAQ
Director John Freund acquired 8,791 shares of SI-BONE, Inc. through the settlement of restricted stock units.
NASDAQ
Director Jeffrey W. Dunn reports acquisition and transfer of SI-BONE common stock, including shares from restricted stock units and a transfer to a living trust.
NASDAQ
Director Timothy E. Davis Jr. acquired 8,791 shares of SI-BONE common stock on June 26, 2024, through the settlement of restricted stock units.
NASDAQ
Director Mika Nishimura reports acquiring 8,791 shares of SI-BONE common stock through restricted stock units.
NASDAQ
Director Gregory K. Hinckley reports acquisition of shares through restricted stock units and disposal of shares held as community property.
NASDAQ
Director Jeryl L. Hilleman reports acquiring 8,791 shares of SI-BONE, Inc. common stock through the settlement of restricted stock units.
NASDAQ
CEO Laura Francis reports exercising stock options and transferring shares to a trust.
NASDAQ
Director Jeffrey W. Dunn sold 341 shares of SI-BONE, Inc. to cover tax withholding obligations related to vesting restricted stock units.
NASDAQ
Anthony J. Recupero, President of Commercial Operations at SI-BONE, Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.
NASDAQ
Anshul Maheshwari, CFO of SI-BONE, Inc., sold shares of common stock on May 16, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
Director Jeffrey W. Dunn sold 1,581 shares of SI-BONE, Inc. to cover tax withholding obligations related to vesting restricted stock units.
NASDAQ
Director Jeffrey W. Dunn sold 343 shares of SI-BONE, Inc. to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
Anthony Recupero, President of Commercial Operations at SI-BONE, Inc., sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
Anshul Maheshwari, CFO of SI-BONE, Inc., sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
Anthony J. Recupero, President of Commercial Operations at SI-BONE, Inc., sold 3,330 shares of common stock at a price of $16.8237 per share under a pre-arranged 10b5-1 trading plan.
NASDAQ
Director Mika Nishimura of SI-BONE, Inc. sold 2,500 shares of common stock at a price of $16.22 on March 13, 2024.